Advertisement

Ads Placeholder
Loading...

Revolution Medicines, Inc. Warrant

RVMDW•NASDAQ
Healthcare
Biotechnology
$1.93
$0.10(5.46%)
U.S. Market opens in 26h 36m

Revolution Medicines, Inc. Warrant (RVMDW) Stock Overview

Explore Revolution Medicines, Inc. Warrant’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap382.5M
P/E Ratio-16.66
EPS (TTM)N/A
ROE-0.63%
Fundamental Analysis

AI Price Forecasts

1 Month$2.34
3 Months$2.50
1 Year Target$2.48

RVMDW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Revolution Medicines, Inc. Warrant (RVMDW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.66 and a market capitalization of 382.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.46%
5-Day Change
20.63%
1-Month Change
-4.46%
3-Month Change
107.55%
6-Month Change
548.96%
Year-to-Date (YTD) Change
107.55%
1-Year Change
4725.00%
3-Year Change
93.02%
5-Year Change
93.02%
All-Time (Max) Change
93.02%

Contact Information

https://www.revmed.com
650 481 6801
700 Saginaw Drive, Redwood City, CA, 94063

Company Facts

6,160 Employees
IPO DateFeb 13, 2020
CountryUS
Actively Trading

Frequently Asked Questions